495 related articles for article (PubMed ID: 10229821)
41. Bcl-x protects primary B cells against Fas-mediated apoptosis.
Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
[TBL] [Abstract][Full Text] [Related]
42. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients.
Schirmer M; Vallejo AN; Weyand CM; Goronzy JJ
J Immunol; 1998 Jul; 161(2):1018-25. PubMed ID: 9670983
[TBL] [Abstract][Full Text] [Related]
43. Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity.
Palathumpat V; Dejbakhsh-Jones S; Holm B; Wang H; Liang O; Strober S
J Immunol; 1992 Jan; 148(2):373-80. PubMed ID: 1309556
[TBL] [Abstract][Full Text] [Related]
44. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Sharabi A; Lapter S; Mozes E
J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
[TBL] [Abstract][Full Text] [Related]
45. IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance.
Tamada K; Harada M; Abe K; Li T; Nomoto K
J Immunol; 1998 Aug; 161(3):1239-47. PubMed ID: 9686584
[TBL] [Abstract][Full Text] [Related]
46. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
[TBL] [Abstract][Full Text] [Related]
47. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
Tamura A; Yui K
J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
[TBL] [Abstract][Full Text] [Related]
48. Distinct methylation states of the CD8 beta gene in peripheral T cells and intraepithelial lymphocytes.
Hamerman JA; Page ST; Pullen AM
J Immunol; 1997 Aug; 159(3):1240-6. PubMed ID: 9233619
[TBL] [Abstract][Full Text] [Related]
49. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes.
Hornung F; Zheng L; Lenardo MJ
J Immunol; 1997 Oct; 159(8):3816-22. PubMed ID: 9378969
[TBL] [Abstract][Full Text] [Related]
50. Functional double-negative T cells in the periphery express T cell receptor V beta gene products that cause deletion of single-positive T cells.
Martínez C; Marcos MA; de Alboran IM; Alonso JM; de Cid R; Kroemer G; Coutinho A
Eur J Immunol; 1993 Jan; 23(1):250-4. PubMed ID: 8419177
[TBL] [Abstract][Full Text] [Related]
51. Induction of apoptosis in mature T cells by tumour necrosis factor.
Zheng L; Fisher G; Miller RE; Peschon J; Lynch DH; Lenardo MJ
Nature; 1995 Sep; 377(6547):348-51. PubMed ID: 7566090
[TBL] [Abstract][Full Text] [Related]
52. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.
Gougeon ML; Lecoeur H; Boudet F; Ledru E; Marzabal S; Boullier S; Roué R; Nagata S; Heeney J
J Immunol; 1997 Mar; 158(6):2964-76. PubMed ID: 9058836
[TBL] [Abstract][Full Text] [Related]
53. Regulation of CD27 expression on subsets of mature T-lymphocytes.
Hintzen RQ; de Jong R; Lens SM; Brouwer M; Baars P; van Lier RA
J Immunol; 1993 Sep; 151(5):2426-35. PubMed ID: 7689607
[TBL] [Abstract][Full Text] [Related]
54. Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice.
Mimura T; Minota S; Nojima Y; Morino N; Hamasaki K; Furuya H; Yazaki Y
J Immunol; 1997 Mar; 158(6):2977-83. PubMed ID: 9058837
[TBL] [Abstract][Full Text] [Related]
55. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
[TBL] [Abstract][Full Text] [Related]
56. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
[TBL] [Abstract][Full Text] [Related]
57. Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen.
Dooms H; Desmedt M; Vancaeneghem S; Rottiers P; Goossens V; Fiers W; Grooten J
J Immunol; 1998 Sep; 161(5):2141-50. PubMed ID: 9725205
[TBL] [Abstract][Full Text] [Related]
58. Fas/Fas ligand signaling during gestational T cell development.
Fleck M; Zhou T; Tatsuta T; Yang P; Wang Z; Mountz JD
J Immunol; 1998 Apr; 160(8):3766-75. PubMed ID: 9558079
[TBL] [Abstract][Full Text] [Related]
59. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.
Josien R; Wong BR; Li HL; Steinman RM; Choi Y
J Immunol; 1999 Mar; 162(5):2562-8. PubMed ID: 10072496
[TBL] [Abstract][Full Text] [Related]
60. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
